Fludarabine in chronic leukaemia

被引：4

作者：

Astrow, AB ^{[1
]}

机构：

[1] ST VINCENTS HOSP & MED CTR,SECT ONCOL,NEW YORK,NY 10011

来源：

LANCET | 1996年 / 347卷 / 9013期

关键词：

D O I：

10.1016/S0140-6736(96)91675-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1420 / 1421

页数：2

共 10 条

[1] INFECTIOUS AND IMMUNOSUPPRESSIVE COMPLICATIONS OF PURINE ANALOG THERAPY [J].

CHESON, BD .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) :2431-2448

[2] FLUDARABINE PHOSPHATE - A SYNTHETIC PURINE ANTIMETABOLITE WITH SIGNIFICANT ACTIVITY AGAINST LYMPHOID MALIGNANCIES [J].

CHUN, HG ;

LEYLANDJONES, B ;

CHESON, BD .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) :175-188

[3]

GREVER MR, 1988, NOUV REV FR HEMATOL, V30, P457

[4] FLUDARABINE - A NEW AGENT WITH MARKED CYTOREDUCTIVE ACTIVITY IN UNTREATED CHRONIC LYMPHOCYTIC-LEUKEMIA [J].

KEATING, MJ ;

KANTARJIAN, H ;

OBRIEN, S ;

KOLLER, C ;

TALPAZ, M ;

SCHACHNER, J ;

CHILDS, CC ;

FREIREICH, EJ ;

MCCREDIE, KB .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) :44-49

[5]

KEATING MJ, 1989, BLOOD, V74, P19

[6]

OBRIEN S, 1993, BLOOD, V82, P1695

[7]

OBRIEN S, 1995, BLOOD, V85, P307

[8]

Rai K. R., 1995, Blood, V86, p607A

[9]

ROZMAN R, 1995, NEW ENGL J MED, V333, P1052

[10]

TALLMAN MS, 1995, BLOOD, V86, P2463

← 1 →